Results 131 to 140 of about 12,413,959 (307)
ABSTRACT Introduction To enhance the treatment quality in haemophilia centres (HC), the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research (GTH) started in 2017 the development of guidelines to define the structural and process quality of HC, essentially related to the EUHANET guidelines.
Hermann Eichler +18 more
wiley +1 more source
Mutation analysis and characterisation of F9 gene in haemophilia- B population of India. [PDF]
Kulkarni S +8 more
europepmc +1 more source
Haemophilia B (Christmas disease) is a rare genetic coagulopathy. It is caused by deficiency of coagulation factor IX due to inherited mutation of gene located on X chromosome. Disease commonly affects male population and its presentation depends on severity of clotting protein shortage.
openaire +2 more sources
Genetic analysis in a female manifesting haemophilia B [PDF]
Stephen Palmer +3 more
openalex +1 more source
Abstract Introduction Haemophilic knee arthropathy leads to a reduction in muscle mass and strength. Blood flow restriction (BFR) involves the application of a compressive cuff that enables strength training with reduced loads. Objective To evaluate safety as the primary outcome and the efficacy (muscle strength and activation, functional capacity and ...
Mar Villalón‐González +4 more
wiley +1 more source
ABSTRACT Introduction Despite therapeutic achievements in haemophilia care, there is still the need to monitor and define personal treatment outcomes and document results to achieve the best possible care. Hence, a need for unbiased, timely and comprehensive real‐world information exists to support informed shared decision‐making regarding treatment ...
Christoph Königs +9 more
wiley +1 more source
Preclinical development of plant-based oral immune modulatory therapy for haemophilia B. [PDF]
Srinivasan A +6 more
europepmc +1 more source
Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre [PDF]
Davi de Podestá Haje +6 more
openalex +1 more source
ABSTRACT Background Rotational thromboelastometry (ROTEM) aims to measure the coagulation potential in whole blood. Concizumab, an anti‐tissue factor pathway inhibitor (TFPI) antibody for prophylaxis in haemophilia, enhances tissue factor (TF)‐initiated coagulation by preventing inhibition of activated factor X (FXa), thus increasing thrombin ...
Hermann Eichler +9 more
wiley +1 more source
ABSTRACT Background People with haemophilia (PwH) are at increased risk of joint bleeding, often leading to haemophilic arthropathy. The Haemophilia Joint Health Score (HJHS) is widely used to evaluate joint health, but its interpretability is limited by the lack of age‐based reference values.
Khang T. Nguyen +5 more
wiley +1 more source

